Abstract:Subclinical hypothyroidism (SH) is common, especially among elderly women. There is no clear evidence to date that SH causes clinical heart disease. However, mild thyroid gland failure, evidenced solely by elevation of the serum thyrotropin (TSH) concentration, may be associated with increased morbidity, particularly for cardiovascular disease, and subtly decreased myocardial contractility. In SH, both cardiac structures and function remain normal at rest, but impaired ventricular function as well as cardiovascular and respiratory adaptation to effort may become unmasked during exercise. These changes are reversible when euthyroidism is restored. Flow-mediated vasodilatation, a marker of endothelial function, is significantly impaired in SH, and decreased heart rate variability, a marker of autonomic activity, suggests hypofunctional abnormalities in the parasympathetic nervous system. SH does result in a small increase in low-density lipoprotein (LDL) cholesterol (C) and a decrease in high-density lipoprotein (HDL)-C, changes that enhance the risk for development of atherosclerosis and coronary artery disease (CAD). After coronary revascularization, a trend toward higher rates of chest pain, dissection, and reocclusion has been noted in SH subjects. Smoking may contribute to the high incidence of SH and may aggravate its metabolic effects. Subjects with SH with marked TSH elevation and high titers of thyroid autoantibodies are at higher risk of unnoticed progression to overt hypothyroidism. Especially women over 50 years with TSH levels greater than 10 mU/L and smoking habits have the highest risk for cardiovascular complications. The magnitude of the lipid changes and the subtle impairment of left ventricular function and cardiopulmonary exercise capacity in SH may justify use of hormone replacement. Early levothyroxine (LT4) treatment in SH may reduce the C level by an average of 8% and normalize all metabolic effects in smokers, nevertheless, in some patients, LT4 therapy may exacerbate angina pectoris or an underlying cardiac arrhythmia. Longitudinal follow-up to define the actual cardiovascular disease risk associated with SH is warranted.

Thyrotropin Aggravates Atherosclerosis by Promoting Macrophage Inflammation in Plaques.

Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagy

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1β Contributing to Atherosclerosis Progression.

Follicle-Stimulating Hormone Provokes Macrophages to Secrete IL-1b Contributing to Atherosclerosis Progression

Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation

Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients

TSH Activates Macrophage Inflammation by G13- and G15-dependent Pathways

Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis.

Effects of Thyroid Hormone Status on Metabolic Pathways of Arachidonic Acid in Mice and Humans: A Targeted Metabolomic Approach.

A novel role for thyroid-stimulating hormone: Up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protei

Correlation of Subclinical Hypothyroidism and Carotid Atherosclerosis in Patients with Essential Hypertension

Macrophages Promote Atherosclerosis Development by Inhibiting CD8T Cell Apoptosis

Deficiency of 5-HT2B receptors alleviates atherosclerosis by regulating macrophage phenotype through inhibiting interferon signalling

Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids

Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance

Up-Regulated Atp-Sensitive Potassium Channels Play A Role in Increased Inflammation and Plaque Vulnerability in Macrophages

MicroRNA-216a Promotes M1 Macrophages Polarization and Atherosclerosis Progression by Activating Telomerase Via the Smad3/NF-κB Pathway.

Cardiovascular and atherogenic aspects of subclinical hypothyroidism

Tanyu Tongzhi Formula Delays Atherosclerotic Plaque Progression by Promoting Alternative Macrophage Activation via PPARγ and AKT/ERK Signal Pathway in ApoE Knock-Out Mice

Thyroid-stimulating hormone induces insulin resistance in adipocytes via endoplasmic reticulum stress